 | 3/27/2012 - After first denying approval for the obesity drug Qnexa (phentermine and topiramate) back in 2010 because of its harrowing side effects, the U.S. Food and Drug Administration (FDA) is now under intense pressure by Big Pharma-backed lawmakers, institutionalized drug pushers, and even its own advisory...
|